title: Oral squamous cell carcinoma in a patient treated with long-term pegylated liposomal doxorubicin for recurrent ovarian cancer.
abstract: We present a case of a woman who developed an oral squamous cell carcinoma (SCC) after being treated for a recurrent ovarian carcinoma with subtotal gastric resection and adjuvant pegylated liposomal doxorubicin (PLD). She received six cycles of PLD induction and maintenance therapy, which was continued for 5 years. She was free from disease at the following visits but 3 years later she developed SCC of her left inferior edentulous gums. The patient was negative for human papillomavirus and had never smoked in her life or had a history of alcohol use or any other environmental risk factors. PLD is known to accumulate in eccrine glands of the hands and the feet and in the oral mucosa, therefore causing skin toxicity and mucositis. It is conceivable that this specific biodistribution to the oral mucosa may be responsible for the onset of SCC.
authors.affiliation: ENT Department, Mauriziano Hospital, Torino, Italy.
authors.forename: Matteo
authors.initials: M
authors.lastname: Pezzoli
authors.affiliation: ENT Department, Mauriziano Hospital, Torino, Italy.
authors.forename: Maurizio
authors.initials: M
authors.lastname: Bona Galvagno
authors.affiliation: ENT Department, Mauriziano Hospital, Torino, Italy.
authors.forename: Guido
authors.initials: G
authors.lastname: Bongioannini
mesh_terms: D000328:Adult; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced*; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D009062:Mouth Neoplasms / Q000139:chemically induced*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000601:surgery; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: C506643:liposomal doxorubicin; D011092:Polyethylene Glycols; D004317:Doxorubicin